@neutronicLSE It’s most likely the deal which is keeping Simon Bennett in post, despite the new arrivals. This has to be the only explanation ?!? #AVCT
Which leads me to think there must be a deal of some kind in the pipeline which he’s been involved with otherwise he shouldn’t/wouldn’t be there. #avct
@AndrewDigby3 I do wonder whether fingers have been burned by the ATHs that followed the LFT that no one purchased. I think we have to sit tight a little longer and take encouragement from every scientific step. I’m in until the science says otherwise #avct
Sad to see #ETH go. Genuinely wanted him to succeed but bad decisions + injuries aside, we aren’t getting better, we still don’t have a style of play and some of the signings (e.g. Zirkzee + Mount) have been awful! #MUFC
@Mike182035@SwiftSlider@w82497 Sound logic and a good plan. I genuinely hope you’re right but, and there is a but, updates of a commercial nature are still possible - I.e. addressable markets are X which has a potential value of Y; or we’ve filed for patents in respect of Z etc etc.
Questions to fellow #AVCT SHs… is anyone aware of what Simon Bennett has been doing? Seems odd that as a Biz Dev person, he doesn’t appear to have more of an external presence (unless I’m looking in the wrong places) - reposting CCs updates doesn’t count (for me at least).
@Mike182035@SwiftSlider@w82497 Unfortunately it seems that way on AIM but in turn that leads me to question initial valuation given the CoS + breadth of what #AVCT now offers vs what it started with, is poles apart.
In any event, I go back to my initial request of better (or even some) commercial updates!
@SwiftSlider@w82497 Agreed but I’m not sure he needs to disclose anything sensitive in order to provide a useful update. I can’t fault the science related comms but evidently the market isn’t valuing that properly which leads to be think only commercial subject matter can make a difference to the SP
@w82497 Plenty of time for this AFTER he’s helped #AVCT to fulfil its potential.
Notwithstanding exclusivity + confidentiality restrictions, I’d hope to have seen some commercial updates from him to supplement the incredible scientific ones from CC!